miércoles, 18 de enero de 2017

Rucaparib Camsylate - National Cancer Institute

Rucaparib Camsylate - National Cancer Institute

National Cancer Institute

Rucaparib Camsylate

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
(roo-KA-puh-rib KAM-suh-layt)
This page contains brief information about rucaparib camsylate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
FDA Approved

Use in Cancer

Rucaparib camsylate is approved to treat:
Rucaparib camsylate is also being studied in the treatment of other types of cancer.

More About Rucaparib Camsylate

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Clinical Trials Accepting Patients

Find Clinical Trials for Rucaparib Camsylate - Check for trials from NCI's list of cancer clinical trials now accepting patients.
  • Posted: January 3, 2017
  • Updated: January 10, 2017

No hay comentarios:

Publicar un comentario